PRIMITIVE NEUROECTODERMAL TUMOUR

PRIMITIVE NEUROECTODERMAL TUMOUR was reported 54 times

PRIMITIVE NEUROECTODERMAL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 2 0.0009
1 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
2 Topoisomerase Inhibitor [EPC] 24 0.0003
3 Histone Deacetylase Inhibitor [EPC] 1 0.0003
4 Somatostatin Analog [EPC] 1 0.0001
5 Alkylating Drug [EPC] 29 0.0001
6 Platinum-based Drug [EPC] 25 0.0001
7 Leukocyte Growth Factor [EPC] 10 0.0001
8 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
9 Recombinant Human Growth Hormone [EPC] 1 0.0000
10 Nucleoside Metabolic Inhibitor [EPC] 10 0.0000
11 Penem Antibacterial [EPC] 1 0.0000
12 Folate Analog Metabolic Inhibitor [EPC] 10 0.0000
13 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
14 Retinoid [EPC] 5 0.0000
15 Parathyroid Hormone Analog [EPC] 2 0.0000
16 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
17 Glycopeptide Antibacterial [EPC] 1 0.0000
18 Nitroimidazole Antimicrobial [EPC] 1 0.0000
19 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
20 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
21 Purine Antimetabolite [EPC] 1 0.0000
22 Aromatase Inhibitor [EPC] 1 0.0000
23 Calcium [EPC] 1 0.0000
24 Microtubule Inhibitor [EPC] 1 0.0000
25 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
26 Interferon beta [EPC] 1 0.0000
27 Mood Stabilizer [EPC] 1 0.0000
28 Anti-epileptic Agent [EPC] 1 0.0000
29 Opioid Agonist [EPC] 1 0.0000
30 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
31 Corticosteroid [EPC] 3 0.0000
32 Kinase Inhibitor [EPC] 1 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 1 0.0000